These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37736329)

  • 41. Erratum: Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum].
    Diabetes Metab Syndr Obes; 2021; 14():3109. PubMed ID: 34262314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease.
    Pereira ENGDS; Silvares RR; Flores EEI; Rodrigues KL; Daliry A
    Microcirculation; 2020 Apr; 27(3):e12603. PubMed ID: 31876010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erratum: Daily Intake of
    Diabetes Metab Syndr Obes; 2020; 13():1609. PubMed ID: 32494177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erratum: 2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione Isolated from
    Diabetes Metab Syndr Obes; 2020; 13():5015. PubMed ID: 33376370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease.
    Ma Y; Kan C; Qiu H; Liu Y; Hou N; Han F; Shi J; Sun X
    Front Pharmacol; 2021; 12():793586. PubMed ID: 34992540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease.
    Pokharel A; Kc S; Thapa P; Karki N; Shrestha R; Jaishi B; Paudel MS
    Cureus; 2021 Jul; 13(7):e16687. PubMed ID: 34466320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erratum: (-)-Epigallocatechin-3-Gallate Inhibits eNOS Uncoupling and Alleviates High Glucose-Induced Dysfunction and Apoptosis of Human Umbilical Vein Endothelial Cells by PI3K/AKT/eNOS Pathway [Corrigendum].
    Diabetes Metab Syndr Obes; 2020; 13():2751. PubMed ID: 32848435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erratum: Health-Related Quality of Life and Associated Factors Among Type Two Diabetic Patients on Follow-Up in Dessie Comprehensive Specialized Hospital, Dessie, North East Ethiopia, 2020 [Corrigendum].
    Diabetes Metab Syndr Obes; 2021; 14():751. PubMed ID: 33628040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erratum: Magnitude of Obesity/Overweight and Its Associated Factors Among HIV/AIDS Patients on Antiretroviral Therapy in Jimma Zone Hospitals, SouthWest Ethiopia: Hospital-Based Cross-Sectional Study [Corrigendum].
    Diabetes Metab Syndr Obes; 2020; 13():1619. PubMed ID: 32494179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erratum 22(1), 22(2), 22(3) and 22(4).
    Epilepsy Curr; 2023; 23(1):61-62. PubMed ID: 36923327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erratum.
    Sci Technol Adv Mater; 2016; 17(1):188. PubMed ID: 27889790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erratum.
    Cardiol Plus; 2022; 7(3):148-149. PubMed ID: 36399088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corrigendum: Cost-effectiveness of adding empagliflozin to the standard therapy for Heart Failure with Preserved Ejection Fraction from the perspective of healthcare systems in China.
    Jiang Y; Xie J
    Front Cardiovasc Med; 2023; 10():1205721. PubMed ID: 37229224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corrigendum to "Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp".
    Mahamid M; Abu-Elhija O; Yassin T; Nseir W
    Can J Gastroenterol Hepatol; 2017; 2017():9042568. PubMed ID: 29445719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Corrigendum.
    Eur Heart J Digit Health; 2022 Dec; 3(4):658. PubMed ID: 36716107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erratum.
    JPGN Rep; 2022 Feb; 3(1):e161. PubMed ID: 37168761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erratum.
    Heart Rhythm O2; 2021 Feb; 2(1):111-112. PubMed ID: 34113912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erratum.
    Cardiovasc Digit Health J; 2021 Apr; 2(2):150-151. PubMed ID: 35265901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erratum to:
    Pilot and Feasibility Studies
    Pilot Feasibility Stud; 2017; 3():48. PubMed ID: 29123916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erratum: Publisher Correction to
    BioMed Central
    EJNMMI Radiopharm Chem; 2018 Dec; 3():13. PubMed ID: 31329807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.